vs

Side-by-side financial comparison of CAPRICOR THERAPEUTICS, INC. (CAPR) and PURE CYCLE CORP (PCYO). Click either name above to swap in a different company.

CAPRICOR THERAPEUTICS, INC. is the larger business by last-quarter revenue ($11.1M vs $9.1M, roughly 1.2× PURE CYCLE CORP). PURE CYCLE CORP runs the higher net margin — 50.0% vs -63.9%, a 113.9% gap on every dollar of revenue. On growth, PURE CYCLE CORP posted the faster year-over-year revenue change (58.8% vs -7.9%). Over the past eight quarters, CAPRICOR THERAPEUTICS, INC.'s revenue compounded faster (93.0% CAGR vs 69.0%).

Capricor Therapeutics is a clinical-stage biotechnology company focused on discovering, developing and commercializing innovative biological therapies including cell and gene therapies for rare diseases, cardiovascular disorders and muscular conditions. It primarily operates in the U.S. market, addressing unmet medical needs for patient groups with limited treatment options.

Pure Cycles, is a bicycle company based in Los Angeles, California that was founded by Michael Fishman, Jordan Schau, Zachary Schau and Austin Stoffers in 2010, as Pure Fix Cycles.

CAPR vs PCYO — Head-to-Head

Bigger by revenue
CAPR
CAPR
1.2× larger
CAPR
$11.1M
$9.1M
PCYO
Growing faster (revenue YoY)
PCYO
PCYO
+66.7% gap
PCYO
58.8%
-7.9%
CAPR
Higher net margin
PCYO
PCYO
113.9% more per $
PCYO
50.0%
-63.9%
CAPR
Faster 2-yr revenue CAGR
CAPR
CAPR
Annualised
CAPR
93.0%
69.0%
PCYO

Income Statement — Q4 FY2024 vs Q1 FY2026

Metric
CAPR
CAPR
PCYO
PCYO
Revenue
$11.1M
$9.1M
Net Profit
$-7.1M
$4.6M
Gross Margin
68.4%
Operating Margin
-69.1%
48.0%
Net Margin
-63.9%
50.0%
Revenue YoY
-7.9%
58.8%
Net Profit YoY
-833.8%
16.0%
EPS (diluted)
$-0.11
$0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAPR
CAPR
PCYO
PCYO
Q4 25
$9.1M
Q3 25
$11.2M
Q2 25
$5.1M
Q1 25
$4.0M
Q4 24
$11.1M
$5.8M
Q3 24
$2.3M
$12.6M
Q2 24
$4.0M
$7.6M
Q1 24
$4.9M
$3.2M
Net Profit
CAPR
CAPR
PCYO
PCYO
Q4 25
$4.6M
Q3 25
$6.1M
Q2 25
$2.3M
Q1 25
$809.0K
Q4 24
$-7.1M
$3.9M
Q3 24
$-12.6M
$6.6M
Q2 24
$-11.0M
$2.8M
Q1 24
$-9.8M
$118.0K
Gross Margin
CAPR
CAPR
PCYO
PCYO
Q4 25
68.4%
Q3 25
67.7%
Q2 25
63.4%
Q1 25
38.2%
Q4 24
63.8%
Q3 24
77.8%
Q2 24
64.0%
Q1 24
55.6%
Operating Margin
CAPR
CAPR
PCYO
PCYO
Q4 25
48.0%
Q3 25
53.1%
Q2 25
26.0%
Q1 25
-33.2%
Q4 24
-69.1%
29.9%
Q3 24
-575.2%
62.0%
Q2 24
-291.9%
40.3%
Q1 24
-209.2%
-11.5%
Net Margin
CAPR
CAPR
PCYO
PCYO
Q4 25
50.0%
Q3 25
54.5%
Q2 25
43.9%
Q1 25
20.3%
Q4 24
-63.9%
68.4%
Q3 24
-555.2%
52.6%
Q2 24
-277.0%
37.2%
Q1 24
-199.6%
3.7%
EPS (diluted)
CAPR
CAPR
PCYO
PCYO
Q4 25
$0.19
Q3 25
$0.26
Q2 25
$0.09
Q1 25
$0.03
Q4 24
$-0.11
$0.16
Q3 24
$-0.38
$0.27
Q2 24
$-0.35
$0.12
Q1 24
$-0.31
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAPR
CAPR
PCYO
PCYO
Cash + ST InvestmentsLiquidity on hand
$151.5M
$17.1M
Total DebtLower is stronger
$8.0M
Stockholders' EquityBook value
$145.5M
$147.5M
Total Assets
$170.5M
$168.1M
Debt / EquityLower = less leverage
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAPR
CAPR
PCYO
PCYO
Q4 25
$17.1M
Q3 25
$21.9M
Q2 25
$14.4M
Q1 25
$16.5M
Q4 24
$151.5M
$19.0M
Q3 24
$85.0M
$22.1M
Q2 24
$29.5M
$20.5M
Q1 24
$39.9M
$20.6M
Total Debt
CAPR
CAPR
PCYO
PCYO
Q4 25
$8.0M
Q3 25
$6.8M
Q2 25
$6.9M
Q1 25
$6.9M
Q4 24
$6.9M
Q3 24
$6.9M
Q2 24
Q1 24
Stockholders' Equity
CAPR
CAPR
PCYO
PCYO
Q4 25
$147.5M
Q3 25
$142.7M
Q2 25
$136.7M
Q1 25
$134.4M
Q4 24
$145.5M
$133.6M
Q3 24
$68.3M
$129.7M
Q2 24
$11.5M
$123.2M
Q1 24
$18.4M
$120.4M
Total Assets
CAPR
CAPR
PCYO
PCYO
Q4 25
$168.1M
Q3 25
$162.3M
Q2 25
$151.7M
Q1 25
$149.7M
Q4 24
$170.5M
$149.7M
Q3 24
$93.0M
$147.4M
Q2 24
$38.3M
$140.4M
Q1 24
$49.4M
$135.2M
Debt / Equity
CAPR
CAPR
PCYO
PCYO
Q4 25
0.05×
Q3 25
0.05×
Q2 25
0.05×
Q1 25
0.05×
Q4 24
0.05×
Q3 24
0.05×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAPR
CAPR
PCYO
PCYO
Operating Cash FlowLast quarter
$-14.8M
$-979.0K
Free Cash FlowOCF − Capex
$-15.3M
FCF MarginFCF / Revenue
-137.3%
Capex IntensityCapex / Revenue
4.4%
Cash ConversionOCF / Net Profit
-0.21×
TTM Free Cash FlowTrailing 4 quarters
$-41.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAPR
CAPR
PCYO
PCYO
Q4 25
$-979.0K
Q3 25
$9.4M
Q2 25
$-503.0K
Q1 25
$-1.4M
Q4 24
$-14.8M
$5.7M
Q3 24
$-11.6M
$3.1M
Q2 24
$-12.3M
$892.0K
Q1 24
$-1.3M
$-457.0K
Free Cash Flow
CAPR
CAPR
PCYO
PCYO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-15.3M
Q3 24
$-11.7M
Q2 24
$-12.3M
Q1 24
$-1.9M
FCF Margin
CAPR
CAPR
PCYO
PCYO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-137.3%
Q3 24
-515.2%
Q2 24
-310.9%
Q1 24
-38.3%
Capex Intensity
CAPR
CAPR
PCYO
PCYO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
4.4%
Q3 24
0.4%
Q2 24
1.5%
Q1 24
12.4%
Cash Conversion
CAPR
CAPR
PCYO
PCYO
Q4 25
-0.21×
Q3 25
1.53×
Q2 25
-0.22×
Q1 25
-1.70×
Q4 24
1.44×
Q3 24
0.47×
Q2 24
0.32×
Q1 24
-3.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAPR
CAPR

Segment breakdown not available.

PCYO
PCYO

Construction$6.5M71%
Water And Wastewater Resource Development Segment$2.5M27%

Related Comparisons